Future studies should explore the therapeutic inhibition of miR-21-5p, particularly within the TGF-β1 signalling axis, as a means of attenuating renal fibrosis, so knockdown and overexpression experiments should be performed. The gene discussed is TGFB1; the disease is renal fibrosis.